LENZ Therapeutics (LENZ) stock: insider trades, news & valuation
Strong buyingShare price and insider trades
LENZ Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 4 insiders bought $654K and 1 sold $261K of LENZ stock on the open market, including a cluster buy that began Mar 27, 2026.
Get emailed when insiders cluster-buy stocks like LENZ
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
LENZ insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | $366K | 3 | — | 0 |
| Q4 2025 | $289K | 3 | $261K | 2 |
| Q3 2025 | — | 0 | $10.4M | 6 |
Valuation, profit and volume
Summary
Over the past 12 months, 4 LENZ Therapeutics, Inc. insiders reported open-market purchases totaling $654K, while 1 insider reported sales totaling $261K. The most recent cluster buy began on Mar 27, 2026, when 3 insiders bought a combined $366K. Among insiders with enough purchase history to measure, Daniel R. Chevallard (CFO) has the highest Insider Score at 5. 2 of 8 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Mar 30SEC | Evert B. SchimmelpenninkCEO, President | Buy | 28,08977,289 held (+57%) | $8.95 | $251K | -59.3% | — |
| Mar 30SEC | Daniel R. ChevallardCFO | Buy | 7,50012,886 held (+139%) | $8.57 | $64K | -57.5% | 5 |
| Mar 30SEC | Jeffrey P. GeorgeDirector | Buy | 5,592new position | $8.92 | $50K | -59.1% | — |
| Nov 19SEC | Shawn OlssonChief Commercial Officer | Sell Plan | 5,7884,733 held (−55%) | $26.37 | $153K | -86.2% | — |
| Nov 19SEC | Shawn OlssonChief Commercial Officer | Sell Plan | 4,21210,521 held (−29%) | $25.74 | $108K | -85.8% | — |
| Nov 10SEC | James W MccollumDirector | Buy | 10,500new position | $22.79 | $239K | -84.0% | — |
| Nov 7SEC | Daniel R. ChevallardCFO | Buy | 2,1785,386 held (+68%) | $22.76 | $50K | -84.0% | 5 |
| Nov 7SEC | Daniel R. ChevallardCFO | Buy | 203,208 held (+1%) | $22.71 | $454 | -83.9% | 5 |
| Oct 2SEC | Versant Vantage Ii Gp-Gp, Llc10% Owner | Sell | 83,0661,050,776 held (−7%) | $46.41 | $3.9M | -92.1% | — |
| Oct 2SEC | Versant Vantage Ii Gp-Gp, Llc10% Owner | Sell | 57,502764,250 held (−7%) | $46.41 | $2.7M | -92.1% | — |
| Oct 2SEC | Versant Vantage Ii Gp-Gp, Llc10% Owner | Sell | 49,7011,133,842 held (−4%) | $45.35 | $2.3M | -92.0% | — |
| Oct 2SEC | Versant Vantage Ii Gp-Gp, Llc10% Owner | Sell | 34,405821,752 held (−4%) | $45.35 | $1.6M | -92.0% | — |
| Oct 2SEC | Versant Vantage Ii Gp-Gp, Llc10% Owner | Sell | 1771,050,599 held (−0%) | $47.01 | $8K | -92.2% | — |
| Oct 2SEC | Versant Vantage Ii Gp-Gp, Llc10% Owner | Sell | 123764,127 held (−0%) | $47.01 | $6K | -92.2% | — |
Insiders at LENZ Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Versant Vantage Ii Gp-Gp, Llc10% Owner | — | $10.4M | Oct 2, 2025 | — |
| Evert B. SchimmelpenninkCEO, President | $251K | — | Mar 30, 2026 | — |
| James W MccollumDirector | $239K | — | Nov 10, 2025 | — |
| Daniel R. ChevallardCFO | $114K | — | Mar 30, 2026 | 5 |
| Shawn OlssonChief Commercial Officer | — | $261K | Nov 19, 2025 | — |
| Jeffrey P. GeorgeDirector | $50K | — | Mar 30, 2026 | — |
LENZ stock: common questions
Are LENZ Therapeutics, Inc. insiders buying LENZ stock?
In the past 12 months, 4 insiders reported open-market purchases of LENZ worth $654K. The latest was CEO, President Evert B. Schimmelpennink bought $251K of LENZ at $8.95 — first open-market purchase in our records; raises the stake by 57%.
Are LENZ Therapeutics, Inc. insiders selling LENZ stock?
1 insiders reported sales worth $261K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is LENZ's 52-week range?
Over the past year LENZ has traded between $3.53 and $46.25. It last closed at $3.65 on Oct 9, 2026.